As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
VIAVI Solutions is contributing to NASA's SPHEREx mission, launched on March 11, 2025. The mission, led by NASA's JPL and Caltech, aims to conduct the first all-sky spectral survey in the near-infrared spectrum.
Viavi Solutions upgraded to Buy with a $14 price forecast by Rosenblatt analyst, citing growth in NE segment sales and strong demand in Aerospace and Military sectors. Revenue estimates for 2025 and 2026 are $1.09B and $1.16B, respectively.
Keysight Technologies Inc. is selling Spirent Communications plc's High-Speed Ethernet and Network Security business to Viavi Solutions Inc. The transaction includes $410 million in cash and a $15 million contingent payment, expected to be finalized in 2025.
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.
Needham analyst upgrades Viavi Solutions to Buy with $15 price target after strong quarterly results. Fiscal Q3 revenue and margin outlook also raised.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
